id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-337965-z39q8ebq	Kvernland, Alexandra	Anticoagulation use and Hemorrhagic Stroke in SARS-CoV-2 Patients Treated at a New York Healthcare System	2020-08-24		.txt	text/plain	3750	182	37	The clinical characteristics, underlying stroke mechanism, and outcomes in this particular subset of patients are especially salient as therapeutic anticoagulation becomes increasingly common in the treatment and prevention of thrombotic complications of COVID-19. This is a retrospective observational study including all consecutive patients with radiologic confirmation of acute hemorrhagic stroke during the specified time frame patients admitted to one of three comprehensive stroke centers in New York: NYU Langone Manhattan, NYU Langone Brooklyn (Sunset Park, Brooklyn), and NYU Langone Winthrop (Mineola, Long Island) with hemorrhagic stroke (intracerebral hemorrhage (ICH) or non-aneurysmal subarachnoid hemorrhage (SAH)) hospitalized between March 1, 2020, and May 15, 2020. Clinical variables included history of hypertension, diabetes mellitus, hyperlipidemia, atrial fibrillation, prior intracerebral hemorrhage, home medications (including antiplatelets and anticoagulants), presenting symptoms, initial National Institutes of Health Stroke Scale (NIHSS) score, date of likely stroke symptom onset (based on last known well or abstractors' clinical judgment), ICH score, and the systolic blood pressure (closest to the time of hemorrhagic stroke diagnosis).	./cache/cord-337965-z39q8ebq.txt	./txt/cord-337965-z39q8ebq.txt